The Negative Impact of Sarcopenia on Hepatocellular Carcinoma Treatment Outcomes
Cancers · 24.06.2024 · 16 (13) · 2315
DOI: 10.3390/cancers16132315 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Cancers, online erschienen am 24.06.2024. Verfasst von Annalisa Cespiati und 3 weiteren Autor:innen. Beteiligte Einrichtung: SC Medicina ad Indirizzo Metabolico, Fondazione IRCCS Cà Granda Ospedale Maggiore Policlinico, via F. Sforza 35, 20122 Milan, Italy. Die Arbeit wurde bisher 13-mal zitiert (Crossref) und nennt 142 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Ministero della Salute, Italian Ministry of Health (Ricerca Corrente 2022-Fondazione IRCCS Cà Granda Ospedale Maggiore Policlinico), University of Milan.
Abstract (Originalsprache)
Introduction
Hepatocellular carcinoma (HCC) represents a major global health concern, characterized by evolving etiological patterns and a range of treatment options. Among various prognostic factors, sarcopenia, characterized by loss of skeletal muscle mass, strength, and function, has emerged as a pivotal contributor to HCC outcomes. Focusing on liver transplantation, surgical resection, locoregional treatments, and systemic therapies, this review aims to analyze the impact of sarcopenia on HCC treatment outcomes, shedding light on an underexplored subject in the pursuit of more personalized management.
Methods
A comprehensive literature review was conducted by searching peer-reviewed articles on sarcopenia and treatment outcomes in patients with HCC from inception up to October 2023.
Results
Sarcopenia was found to be prevalent among HCC patients, exhibiting different occurrence, possibly attributable to diverse diagnostic criteria. Notably, despite variations in studies utilizing skeletal muscle indices, sarcopenia independently correlated with lower overall survival (OS), recurrence-free survival (RFS), and progression-free survival (PFS) across surgical (both transplantation and resection), locoregional, and systemic therapies, including tyrosine-kinase inhibitors (TKIs) and immune-checkpoint inhibitors (ICIs). Moreover, a link between sarcopenia and increased rate and severity of adverse events, particularly in surgery and TKIs recipients, and larger tumor size at diagnosis was observed. While baseline sarcopenia negatively influenced treatment outcomes, alterations in muscle mass post-treatment emerged as primary determinants of reduced OS.
Conclusions
Sarcopenia, either present before or after HCC treatment, negatively correlates with response to it, across all etiologies and therapeutic strategies. Although only a few studies have evaluated the impact of supervised physical activity training on muscle mass and OS after HCC treatment, it is crucial to evaluate the presence of sarcopenia before treatment initiation, to better stratify patients’ prognosis, thus performing a more tailored approach, and identify therapies able to restore muscle mass in HCC patients. Conversely, the impact of sarcopenia on HCC recurrence and extrahepatic spread remains inadequately explored.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- SC Medicina ad Indirizzo Metabolico, Fondazione IRCCS Cà Granda Ospedale Maggiore Policlinico, via F. Sforza 35, 20122 Milan, Italy.
- Department of Pathophysiology and Transplantation, University of Milan, 20122 Milan, Italy.
ORCID-Profile: Annalisa Cespiati, Rosa Lombardi, Anna Ludovica Fracanzani
Förderung
- Ministero della Salute
- Italian Ministry of Health (Ricerca Corrente 2022-Fondazione IRCCS Cà Granda Ospedale Maggiore Policlinico)
- University of Milan
Zitieren
APA
Cespiati, A., Smith, D., Lombardi, R., & Fracanzani, A. L. (2024). The Negative Impact of Sarcopenia on Hepatocellular Carcinoma Treatment Outcomes. Cancers, 16(13), 2315. https://doi.org/10.3390/cancers16132315
Vancouver
Cespiati A, Smith D, Lombardi R, Fracanzani AL. The Negative Impact of Sarcopenia on Hepatocellular Carcinoma Treatment Outcomes. Cancers. 2024;16(13):2315. doi:10.3390/cancers16132315
BibTeX
@article{Cespiati2024,
author = {Cespiati, Annalisa and Smith, Daniel and Lombardi, Rosa and Fracanzani, Anna Ludovica},
title = {The Negative Impact of Sarcopenia on Hepatocellular Carcinoma Treatment Outcomes},
journal = {Cancers},
year = {2024},
volume = {16},
number = {13},
pages = {2315},
doi = {10.3390/cancers16132315}
}
EUVIMED